Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-19-031970

President & CEO acquired 4,400 shares (option exercise)

  • President & CEO gave 4,400 shares (gift)
  • President & CEO gave 4,400 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

USMAN NASSIM · President & CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-21 Exercise or conversion : show line 1 in the form +4,400 $4.63 $20,372 10,567 D
2019-05-21 Gift : show line 2 in the form −4,400 6,167 D
2019-05-21 Gift : show line 3 in the form +4,400 8,456 I

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-05-20 Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) −4,400 $4.63 2027-07-11 4,400 264,783 D
Loading xslF345X03/doc4.xml…